Literature DB >> 11435417

The cytoplasmic and transmembrane domains of the p75 and Trk A receptors regulate high affinity binding to nerve growth factor.

D Esposito1, P Patel, R M Stephens, P Perez, M V Chao, D R Kaplan, B L Hempstead.   

Abstract

Ligand-induced receptor oligomerization is an established mechanism for receptor-tyrosine kinase activation. However, numerous receptor-tyrosine kinases are expressed in multicomponent complexes with other receptors that may signal independently or alter the binding characteristics of the receptor-tyrosine kinase. Nerve growth factor (NGF) interacts with two structurally unrelated receptors, the Trk A receptor-tyrosine kinase and p75, a tumor necrosis factor receptor family member. Each receptor binds independently to NGF with predominantly low affinity (K(d) = 10(-9) m), but they produce high affinity binding sites (K(d) = 10(-11) m) upon receptor co-expression. Here we provide evidence that the number of high affinity sites is regulated by the ratio of the two receptors and by specific domains of Trk A and p75. Co-expression of Trk A containing mutant transmembrane or cytoplasmic domains with p75 yielded reduced numbers of high affinity binding sites. Similarly, co-expression of mutant p75 containing altered transmembrane and cytoplasmic domains with Trk A also resulted in predominantly low affinity binding sites. Surprisingly, extracellular domain mutations of p75 that abolished NGF binding still generated high affinity binding with Trk A. These results indicate that the transmembrane and cytoplasmic domains of Trk A and p75 are responsible for high affinity site formation and suggest that p75 alters the conformation of Trk A to generate high affinity NGF binding.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11435417     DOI: 10.1074/jbc.M011674200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

1.  Does NGF binding to p75 and trkA receptors activate independent signalling pathways to sensitize nociceptors?

Authors:  Lorne M Mendell
Journal:  J Physiol       Date:  2002-10-15       Impact factor: 5.182

Review 2.  Regulation of neuronal survival and death by extracellular signals during development.

Authors:  Alun M Davies
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

3.  Proteolytic processing of the p75 neurotrophin receptor and two homologs generates C-terminal fragments with signaling capability.

Authors:  Kevin C Kanning; Mark Hudson; Paul S Amieux; Jesse C Wiley; Mark Bothwell; Leslayann C Schecterson
Journal:  J Neurosci       Date:  2003-07-02       Impact factor: 6.167

Review 4.  Neurotrophins and the immune system.

Authors:  José A Vega; Olivia García-Suárez; Jonas Hannestad; Marta Pérez-Pérez; Antonino Germanà
Journal:  J Anat       Date:  2003-07       Impact factor: 2.610

Review 5.  The involvement of BDNF, NGF and GDNF in aging and Alzheimer's disease.

Authors:  Josiane Budni; Tatiani Bellettini-Santos; Francielle Mina; Michelle Lima Garcez; Alexandra Ioppi Zugno
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

6.  On the presence of neurotrophin p75 receptor on rat sympathetic cerebrovascular nerves.

Authors:  Andrzej Loesch; Tim Cowen
Journal:  J Mol Histol       Date:  2007-08-02       Impact factor: 2.611

7.  Plasticity in rat uterine sympathetic nerves: the role of TrkA and p75 nerve growth factor receptors.

Authors:  Analía Richeri; Paola Bianchimano; Nelson M Mármol; Lorena Viettro; Timothy Cowen; M Mónica Brauer
Journal:  J Anat       Date:  2005-08       Impact factor: 2.610

Review 8.  Targeting myelin to optimize plasticity of spared spinal axons.

Authors:  Angela L M Scott; Leanne M Ramer; Lesley J J Soril; Jacek M Kwiecien; Matt S Ramer
Journal:  Mol Neurobiol       Date:  2006-04       Impact factor: 5.590

Review 9.  Cardiovascular actions of neurotrophins.

Authors:  Andrea Caporali; Costanza Emanueli
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

10.  Comparison of nerve growth factor receptor binding models using heterodimeric muteins.

Authors:  Hrishikesh M Mehta; Sang B Woo; Kenneth E Neet
Journal:  J Neurosci Res       Date:  2012-08-18       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.